U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Bought by Benjamin Edwards Inc.

Benjamin Edwards Inc. lifted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPHFree Report) by 15.4% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,704 shares of the company’s stock after buying an additional 361 shares during the period. Benjamin Edwards Inc.’s holdings in U.S. Physical Therapy were worth $250,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in USPH. Charles Schwab Investment Management Inc. lifted its position in U.S. Physical Therapy by 1.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 152,099 shares of the company’s stock valued at $14,167,000 after buying an additional 2,063 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in U.S. Physical Therapy by 3.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 400,183 shares of the company’s stock valued at $37,274,000 after purchasing an additional 14,344 shares in the last quarter. RK Capital Management LLC purchased a new stake in shares of U.S. Physical Therapy during the 4th quarter valued at about $6,166,000. CenterBook Partners LP acquired a new position in shares of U.S. Physical Therapy during the fourth quarter worth $1,436,000. Finally, Schroder Investment Management Group lifted its holdings in U.S. Physical Therapy by 11.0% in the 4th quarter. Schroder Investment Management Group now owns 427,217 shares of the company’s stock worth $39,791,000 after buying an additional 42,281 shares in the last quarter.

Insider Activity

In related news, Director Kathleen A. Gilmartin acquired 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Tuesday, September 3rd. The stock was acquired at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the transaction, the director now directly owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at approximately $580,635. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares in the company, valued at $1,627,445.36. The disclosure for this purchase can be found here. Corporate insiders own 1.70% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Barrington Research reaffirmed an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research report on Friday.

View Our Latest Stock Report on USPH

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $83.28 on Friday. The company’s 50-day simple moving average is $88.60 and its 200-day simple moving average is $97.03. U.S. Physical Therapy, Inc. has a one year low of $78.08 and a one year high of $113.63. The stock has a market capitalization of $1.25 billion, a price-to-earnings ratio of 67.71, a PEG ratio of 4.11 and a beta of 1.39. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last issued its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The business had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. During the same period last year, the company posted $0.76 earnings per share. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. Equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.51 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were issued a $0.44 dividend. The ex-dividend date was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a yield of 2.11%. U.S. Physical Therapy’s dividend payout ratio is currently 143.09%.

About U.S. Physical Therapy

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPHFree Report).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.